CompaniesByCap
ELOX
Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Healthcare

Eloxx Pharmaceuticals, Inc. Net Income 2010–2025

Eloxx Pharmaceuticals, Inc. annual/quarterly net income history and growth rate from 2010 to 2012. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

  • Eloxx Pharmaceuticals, Inc. net income for the quarter ending December 31, 2012 was -1.3 M, a 16.87% decrease year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual net income for 2025 was -6.0 M, a 90.74% increase from 2024.
  • Eloxx Pharmaceuticals, Inc. annual net income for 2024 was -3.1 M, a 81.57% decrease from 2023.
  • Eloxx Pharmaceuticals, Inc. annual net income for 2023 was -17.1 M, a 84.86% increase from 2014.
  • Eloxx Pharmaceuticals, Inc. annual net income for 2014 was -9.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Eloxx Pharmaceuticals, Inc. Net Income — FAQ

Eloxx Pharmaceuticals, Inc. (ELOX) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.

What is Eloxx Pharmaceuticals, Inc.'s net income?

Eloxx Pharmaceuticals, Inc. (ELOX) reported net income of -$6M for fiscal 2025.

Where can I see ELOX's net income history?

The chart and table above show Eloxx Pharmaceuticals, Inc.'s net income by year and by quarter, including the growth rate.